================================================================ == -- ALS INTEREST GROUP -- == == ALS DIGEST (#16, 04 FEB 1993) == == To subscribe, unsubscribe, or to contribute notes, please == == send e-mail to bro@huey.met.fsu.edu (Bob Broedel). == ================================================================ Here is the result of a recent search using the keyword "CNTF". * PTS NEWSLETTER DATABASE * ENTER SUBJECT WORDS -> cntf System is now searching PTS Newsletter Database, copyrighted 1993 by Predicasts, Inc., Cleveland, OH, and available through Data-Star. TI REGENERON'S NEUROTROPHIC FACTORS PREVENT DEGENERATION OF EYE RETINA CELLS. SO GENETIC-TECHNOLOGY-NEWS, 930100, January 00, 1993, VOLUME 13, ISSUE 1, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 1/92. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI SYNERGEN BELIEVES ITS IL-1ra WILL BE A BLOCK BUSTER. SO GENETIC-TECHNOLOGY-NEWS, 930100, January 00, 1993, VOLUME 13, ISSUE 1, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 1/92. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI CEPHALON TARGETS NERVOUS SYSTEM DISORDERS. SO GENETIC-TECHNOLOGY-NEWS, 930100, January 00, 1993, VOLUME 13, ISSUE 1, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 1/92. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI GTN STRATEGIC PARTNERS REPORT: REGENERON PHARMACEUTICALS; AMERICAN CYANAMID. SO GENETIC-TECHNOLOGY-NEWS, 930100, January 00, 1993, VOLUME 13, ISSUE 1, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 1/92. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI CEPHALON SMALL MOLECULES ACTIVE AGAINST NEURODEGENERATIVE DISEASES. SO GENETIC-TECHNOLOGY-NEWS, 921200, December 00, 1992, VOLUME 12, ISSUE 12, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 1/92. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI NEUROTECHNOLOGY: Cephalon Reports Data on Neurotrophic Factors. SO Applied-Genetics-News, 921100, November 00, 1992, VOLUME 13, ISSUE 4, ISSN NUMBER 0271-7107. PU Business Communications Company, Inc. AV Subscription: $305 per year as of 1/92. Published monthly. Contact Business Communications Company, Inc., 25 Van Zant Street, Norwalk, CT 06855. Phone (203) 853-4266. FAX 203-853-0348. TI Synergen awarded third CNTF patent. SO BIOTECH-Patent-News, 920900, September 00, 1992, VOLUME 6, ISSUE 9, ISSN NUMBER 1898-2813. PU BIOTECH Patent News. AV Subscription: $95 per year as of 1/92. Published monthly. Contact BIOTECH Patent News, P. O. Box 4482, Metuchen, NJ 08840. Phone (201) 549-1356. TI Synergen's CNTF patent. SO Biotechnology-Business-News, 920918, September 18, 1992. PU Financial Times Business Information, Ltd. AV Subscription: 398 British Pound Sterling per year as of 1/91. Published 24 times/year. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI Synergen's Antril trial on schedule. SO Biotechnology-Business-News, 920904, September 04, 1992. PU Financial Times Business Information, Ltd. AV Subscription: 398 British Pound Sterling per year as of 1/91. Published 24 times/year. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI REGENERON AND SYNERGEN BATTLE FOR CNTF PATENT. SO GENETIC-TECHNOLOGY-NEWS, 920900, September 00, 1992, VOLUME 12, ISSUE 9, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 8/91. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI VERDICT IN CNTF PATENT DISPUTE. SO Marketletter, 920907, September 07, 1992, ISSN NUMBER 0140-4288. PU Marketletter (Publications) Ltd. AV Subscription: 440 British Pound Sterling per year as of 1/92. Published weekly. Contact Marketletter (Publications) Ltd., 54/55 Wilton Rd., London SW1V 1DE, UK. Phone (71) 828-7272. FAX (71) 828-0415. TI FDA ACTIVITIES:Regeneron Receives FDA Go-Ahead for Nerve Growth Factor Trials. SO Applied-Genetics-News, 920800, August 00, 1992, VOLUME 12, ISSUE 1, ISSN NUMBER 0271-7107. PU Business Communications Company, Inc. AV Subscription: $305 per year as of 1/92. Published monthly. Contact Business Communications Company, Inc., 25 Van Zant Street, Norwalk, CT 06855. Phone (203) 853-4266. FAX 203-853-0348. TI Business Developments; Motor Neuron Disease Orphan Drug. SO BBI-Newsletter, 920715, July 15, 1992, VOLUME 15, ISSUE 7, ISSN NUMBER 1049-4316. PU Biomedical Business International. AV Subscription: $625 per year as of 1/90. Published monthly. Contact Biomedical Business International, 1524 Brookhollow Drive, Santa Ana, CA 92705. Phone (714) 755-5757. FAX (714) 755-5704. TI Orphan drug status for CNTF. SO Biotechnology-Business-News, 920619, June 19, 1992. PU Financial Times Business Information, Ltd. AV Subscription: 398 British Pound Sterling per year as of 1/91. Published 24 times/year. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI Syntex-Synergen joint venture begins ALS Phase I study. SO BIOTECH-Patent-News, 920600, June 00, 1992, VOLUME 6, ISSUE 6, ISSN NUMBER 1898-2813. PU BIOTECH Patent News. AV Subscription: $95 per year as of 1/91. Published monthly. Contact BIOTECH Patent News, P. O. Box 4482, Metuchen, NJ 08840. Phone (201) 549-1356. TI 1991 - "remarkable" for Synergen. SO Biotechnology-Business-News, 920508, May 08, 1992. PU Financial Times Business Information, Ltd. AV Subscription: 398 British Pound Sterling per year as of 1/91. Published 24 times/year. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI Milestones on the Road to the Marketplace. SO GENETIC-TECHNOLOGY-NEWS, 920600, June 00, 1992, VOLUME 12, ISSUE >6, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 8/91. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI Syntex/Synergen venture begin ALS Phase I study. SO Pharmaceutical-Business-News, 920515, May 15, 1992. PU Financial Times Business Information, Ltd. AV Subscription: 339 British Pound Sterling per year as of 1/91. Published 24 times/yr. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI REGENERON BEGINS CNTF TRIALS. SO Marketletter, 920511, May 11, 1992, ISSN NUMBER 0140-4288. PU Marketletter (Publications) Ltd. AV Subscription: 440 British Pound Sterling per year as of 1/92. Published weekly. Contact Marketletter (Publications) Ltd., 54/55 Wilton Rd., London SW1V 1DE, UK. Phone (71) 828-7272. FAX (71) 828-0415. TI Application for use of CNTF. SO Pharmaceutical-Business-News, 920403, April 03, 1992. PU Financial Times Business Information, Ltd. AV Subscription: 339 British Pound Sterling per year as of 1/91. Published 24 times/yr. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI Regeneron Concentrates on Recombinant Nerve Growth Factors. SO GENETIC-TECHNOLOGY-NEWS, 920400, April 00, 1992, VOLUME 12, ISSUE 4, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 8/91. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI NEUROTECHNOLOGY:Regeneron Licenses Use of Two Growth Factors. SO Applied-Genetics-News, 920300, March 00, 1992, VOLUME 12, ISSUE 8, ISSN NUMBER 0271-7107. PU Business Communications Company, Inc. AV Subscription: $295 per year as of 1/90. Published monthly. Contact Business Communications Company, Inc., 25 Van Zant Street, Norwalk, CT 06855. Phone (203) 853-4266. FAX 203-853-0348. TI Regeneron Licenses New Nervous System Proteins. SO GENETIC-TECHNOLOGY-NEWS, 920300, March 00, 1992, VOLUME 12, ISSUE 3, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 8/91. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI REGENERON'S CNTF NAMED ORPHAN DRUG. SO Marketletter, 920217, February 17, 1992, ISSN NUMBER 0140-4288. PU Marketletter (Publications) Ltd. AV Subscription: 440 British Pound Sterling per year as of 1/92. Published weekly. Contact Marketletter (Publications) Ltd., 54/55 Wilton Rd., London SW1V 1DE, UK. Phone (71) 828-7272. FAX (71) 828-0415. TI Synergen's products face major tests. SO Pharmaceutical-Business-News, 910621, June 21, 1991. PU Financial Times Business Information, Ltd. AV Subscription: 339 British Pound Sterling per year as of 1/91. Published 24 times/yr. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI Synergen awarded CNTF patent. SO Pharmaceutical-Business-News, 910315, March 15, 1991. PU Financial Times Business Information, Ltd. AV Subscription: 339 British Pound Sterling per year as of 1/91. Published 24 times/yr. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI Synergen awarded additional patent. SO Biotechnology-Business-News, 910503, May 03, 1991. PU Financial Times Business Information, Ltd. AV Subscription: 398 British Pound Sterling per year as of 1/91. Published 24 times/year. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI Cal Bio: profitable by the mid-1990s? SO Biotechnology-Business-News, 911122, November 22, 1991. PU Financial Times Business Information, Ltd. AV Subscription: 398 British Pound Sterling per year as of 1/91. Published 24 times/year. Contact Financial Times Business Information, Ltd., Tower House, Southampton St., London WC2E 7HA, UK. Phone (71) 240-9391. FAX (71) 250-7946. TI REGENERON ACHIEVES SUCCESS WITH ITS EXPERIMENTAL NERVE-GROWTH FACTOR. SO Applied-Genetics-News, 911200, December 00, 1991, VOLUME 12, ISSUE 5, ISSN NUMBER 0271-7107. PU Business Communications Company, Inc. AV Subscription: $295 per year as of 1/90. Published monthly. Contact Business Communications Company, Inc., 25 Van Zant Street, Norwalk, CT 06855. Phone (203) 853-4266. FAX 203-853-0348. TI Regeneron's CNTF Slows Lou Gehrig's Disease in Mice. SO GENETIC-TECHNOLOGY-NEWS, 911200, December 00, 1991, VOLUME 11, ISSUE 12, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 8/91. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI Regeneron Hopes to File IND for Its First Neurotrophic Factor Next Year. SO GENETIC-TECHNOLOGY-NEWS, 911100, November 00, 1991, VOLUME 11, ISSUE 11, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 8/91. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI Regeneron Clones CNTF Receptor. SO GENETIC-TECHNOLOGY-NEWS, 910800, August 00, 1991, VOLUME 11, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $550 per year as of 8/91. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI GTN MARKET FORECAST: Nervous System Proteins -- Therapeutics and Targets. SO GENETIC-TECHNOLOGY-NEWS, 910600, June 00, 1991, VOLUME 11, ISSUE 6, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $480 per year as of 1/90. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI US BIOTECH COMPANIES DEVELOPING NEW NERVOUS SYSTEM PRODUCTS. SO GENETIC-TECHNOLOGY-NEWS, 910600, June 00, 1991, VOLUME 11, ISSUE 6, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $480 per year as of 1/90. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI Synergen CILIARY NEUROTROPHIC FACTOR (CNTF) PATENT AWARDED. SO Cancer-Weekly, 910318, March 18, 1991, ISSN NUMBER 0896-7384. PU Charles W. Henderson. AV Replaces NCI Cancer Weekly. Subscription: $916 per year as of 1/91. Published weekly. Contact Charles W. Henderson, P. O. Box 830409, Birmingham, AL 35283-0409. Phone (800) 633-4931 or (205) 991-6920. FAX (205) 995-1588. TI Synergen CILIARY NEUROTROPHIC FACTOR PATENT AWARDED. SO AIDS-Weekly, 910318, March 18, 1991, ISSN NUMBER 0884-903X. PU Charles W. Henderson. AV Replaces CDC AIDs Weekly. Subscription: $828 per year as of 1/91. Published weekly. Contact Charles W. Henderson, P. O. Box 830409, Birmingham, AL 35283-0409. Phone (800) 633-4931 or (205) 991-6920. FAX (205) 995-1588. TI Synergen, Inc. and Syntex, Inc. SO Alliance-Alert-Medical-Health, 900400, April 00, 1990, VOLUME 1, ISSUE 1, ISSN NUMBER 1050-0367. PU Venture Economics, Inc. AV Subscription: $395 per year as of 4/90. Published quarterly. Contact Venture Economics, Inc., 75 Second Avenue, Suite 700, Needham, MA 02194-2813. Phone (617) 449-2100. FAX (617) 449-7660. TI Synergen Clones New Type of Nervous System Protein, (CNTF). SO GENETIC-TECHNOLOGY-NEWS, 900100, January 00, 1990, VOLUME 10, ISSUE 1, ISSN NUMBER 0272-9032. PU TECHNICAL INSIGHTS, INC. AV Subscription: $480 per year as of 1/90. Published monthly. Contact Technical Insights, Inc., 32 North Dean Street, Englewood, NJ, 07631. Address all mail to P.O. Box 1304, Fort Lee, NJ, 07024. Phone (201) 568-4744. TI Synergen NEW PROTEIN COULD PROTECT AGAINST AIDS DRUG SIDE EFFECTS. SO CDC-Aids-Weekly, 891225, December 25, 1989, ISSN NUMBER 0884-903X. PU Charles W. Henderson. AV Subscription: $676 per year as of 1/89. Published weekly. Contact Charles W. Henderson, P.O. Box 830409, Birmingham, AL 35283-0409. Phone (205) 991-6920. FAX (205) 991-1479. TI Synergen NEW PROTEIN FOR TREATMENT OF NERVOUS SYSTEM DISORDERS. SO NCI-Cancer-Weekly, 891211, December 11, 1989, ISSN NUMBER 0896-7385. PU Charles W. Henderson. AV Subscription: $789 per year as of 1/89. Published weekly. Contact Charles W. Henderson, P.O. Box 830409, Birmingham, AL 35283-0409. Phone (205) 991-6920. FAX (205) 991-1479. TI Synergen NEW PROTEIN FOR TREATMENT OF NERVOUS SYSTEM DISORDERS. SO CDC-Aids-Weekly, 891211, December 11, 1989, ISSN NUMBER 0884-903X. PU Charles W. Henderson. AV Subscription: $676 per year as of 1/89. Published weekly. Contact Charles W. Henderson, P.O. Box 830409, Birmingham, AL 35283-0409. Phone (205) 991-6920. FAX (205) 991-1479. == end of als 16 ==